TOP 100 MEDICAL SITES
| |||
|
| |||
| |||
|
| |||
| Safety 1st TV Snapshot - Video New Video Portal Provides Advice and Tips on Everything from Bathing and Feeding Baby to Home Childproofing feedproxy.google.com |
Robo-Seal: A $6,000 Medical Device Paro, a socially interactive robot developed in Japan, has come to U.S. shores, turning up in a handful of nursing homes and causing a stir in a way that fake baby seals rarely do. online.wsj.com |
FDA Sends Warning to Abbott Diabetes Unit The FDA warned Abbott Laboratories' diabetes unit about manufacturing violations involving blood-glucose monitoring systems. online.wsj.com |
Egg Inspectors Failed to Raise Alarms U.S. Department of Agriculture experts found bugs and trash earlier this year on the Iowa farm at the center of the big recent egg recall, but didn't notify federal health authorities or delay production. online.wsj.com |
Biodel: Upside from Potential Linjeta Approval Rockford Coscia submits:I wanted to weigh in on the Biodel (BIOD) PDUFA for their rapid-acting insulin formulation, Linjeta. Many investigations have taken place here, here, and here (and my first article offered a play that has returned over 50% since July here), but I thought it would be worthwhile to provide a summary of what’s at stake. Linjeta, to provide a little background, is a new formulation of rapid-acting prandial (meal-time) insulin. It is basically regular insulin that has been treated with EDTA to break the hexameric insulin into three dimers. The remaining dimers are treated with citric acid in order to break the dimers into monomers. What results is an insulin that goes to work faster (it doesn’t have to break down in the body from hexamer to monomer) and is supposed to more closely mimic the body’s natural insulin response.Complete Story » seekingalpha.com |